Literature DB >> 58746

Testicular tumours.

M J Peckham, T J McElwain.   

Abstract

With modern methods of diagnosis, staging and treatment, seminoma is a highly curable tumour. The worse results for the treatment of teratomas are likely to improve particularly as methods for detection of the tumour improve and as types of treatment are increasingly combined in a way which takes account of the biology of the tumour and the strength and limitation of each treatment modality. Stage I and II teratoma should receive irradiation after orchidectomy although when bulky retroperitoneal disease is present irradiation alone is rarely capable of securing local tumour control. In these cases chemotherapy may achieve nodal regression preparatory to irradiation. Excision of residual masses after irradiation should be considered in teratoma. Chemotherapy is the treatment of choice for disseminated teratoma but maintaining tumour control poses problems. Whole lung irradiation following chemotherapy is being assessed in selected patients.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 58746     DOI: 10.1016/s0300-595x(75)80052-1

Source DB:  PubMed          Journal:  Clin Endocrinol Metab        ISSN: 0300-595X


  5 in total

1.  Advances in pathology and immunocytochemistry.

Authors:  E Heyderman
Journal:  J R Soc Med       Date:  1985       Impact factor: 5.344

2.  Improved management of testicular tumours.

Authors: 
Journal:  Br Med J       Date:  1979-03-31

3.  Radiation therapy for seminoma of the testis: results in British Columbia.

Authors:  S M Jackson; I Olivotto; M G McLoughlin; P Coy
Journal:  Can Med Assoc J       Date:  1980-09-20       Impact factor: 8.262

4.  The interpretation of marker protein assays: a critical appraisal in clinical studies and a xenograft model.

Authors:  D Raghavan; J Gibbs; R Nogueira Costa; J Kohn; A H Orr; A Barrett; M J Peckham
Journal:  Br J Cancer Suppl       Date:  1980-04

5.  Germ cell tumors of the testes.

Authors:  G D Braunstein
Journal:  West J Med       Date:  1977-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.